OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Yuan Li, Zhiyuan Xu, Shanming Ruan, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 260

Showing 1-25 of 260 citing articles:

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
Simin Qi, Jinyun Dong, Zhiyuan Xu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 201

LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription
Bingqiu Xiu, Yayun Chi, Lei Liu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 179

Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer
Zirui Zhao, Haohan Liu, Xingyu Zhou, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 171

RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma
Yuanbo Cui, Chunyan Zhang, Shanshan Ma, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 110

Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer
Ying Liu, Wei Ding, Wanpeng Yu, et al.
Molecular Therapy — Oncolytics (2021) Vol. 23, pp. 458-476
Open Access | Times Cited: 103

LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability
Yiran Zhu, Bingluo Zhou, Xinyang Hu, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 86

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79

Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer
Yangzi Chen, Bohong Wang, Yizi Zhao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 43

Enhanced Photodynamic Therapy Synergizing with Inhibition of Tumor Neutrophil Ferroptosis Boosts Anti‐PD‐1 Therapy of Gastric Cancer
Xudong Zhu, Wenxuan Zheng, Xingzhou Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 16

Journey of PROTAC: From Bench to Clinical Trial and Beyond
Kyli Berkley, Julian Zalejski, Nidhi Sharma, et al.
Biochemistry (2025)
Closed Access | Times Cited: 2

The protective role of baicalin regulation of autophagy in cancers
Qí Zhāng, Shiyun Guo, Han Ge, et al.
Cytotechnology (2025) Vol. 77, Iss. 1
Closed Access | Times Cited: 1

lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer
Qingzhu Yang, Kai Li, Xuemei Huang, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 19, pp. 974-985
Open Access | Times Cited: 80

Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
Ying Liu, Xiang Ao, Yu Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 65

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer
Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Kehinde Ross, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 65

Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming
Muhua Chen, Chunfeng Zhang, Wei Liu, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2354-2369
Open Access | Times Cited: 48

Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications
Jinxia Chen, Zhiyuan Xu, Can Hu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 34

Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1
Ying Li, Yiwen Xia, Tianlu Jiang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 27

Exosome-mediated miR-200a delivery into TGF-β-treated AGS cells abolished epithelial-mesenchymal transition with normalization of ZEB1, vimentin and Snail1 expression
Sepideh Mirzaei, Mohammad Gholami, Hamid Asadzadeh Aghdaei, et al.
Environmental Research (2023) Vol. 231, pp. 116115-116115
Closed Access | Times Cited: 21

Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers
Yuan Li, Silei Sui, Ajay Goel
Seminars in Cancer Biology (2024) Vol. 99, pp. 5-23
Closed Access | Times Cited: 12

LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57
Guohua Zhang, Ying Xu, Sijia Wang, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 4, pp. 5163-5174
Closed Access | Times Cited: 80

EGR1‐mediated linc01503 promotes cell cycle progression and tumorigenesis in gastric cancer
Zhonghua Ma, Gao X, You Shuai, et al.
Cell Proliferation (2020) Vol. 54, Iss. 1
Open Access | Times Cited: 67

Page 1 - Next Page

Scroll to top